These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 427046)

  • 1. Specificity in the factor VIII response to vasopressin infusion in man.
    Prowse CV; Sas G; Gader AM; Cort JH; Cash JD
    Br J Haematol; 1979 Mar; 41(3):437-47. PubMed ID: 427046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidiuretic activity and release of factor VIII by vasopressin analogues.
    Vilhardt H; Barth T; Melin P; Aurell CJ
    Eur J Pharmacol; 1993 Mar; 232(2-3):223-6. PubMed ID: 8467859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: The release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, I-desamino-8-d-arginine vasopressin, angiotensin and oxytocin in man.
    Cash JD; Gader AM; da Costa J
    Br J Haematol; 1974 Jun; 27(2):363-4. PubMed ID: 4367720
    [No Abstract]   [Full Text] [Related]  

  • 4. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
    Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL
    Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of neurohypophyseal hormone analogues on blood clotting factor VIII and fibrinolytic activity in sheep.
    Neuenschwander S; Pliska V
    Eur J Pharmacol; 1997 Apr; 323(2-3):205-13. PubMed ID: 9128840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities.
    Moffat EH; Giddings JC; Bloom AL
    Br J Haematol; 1984 Aug; 57(4):651-62. PubMed ID: 6430337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characterization of FVIII/VW circulating after DDAVP administration (author's transl)].
    Vicente V; Díez LF; Alberca I; San Miguel J; López Borrasca A
    An Esp Pediatr; 1981 Jun; 14(6):436-43. PubMed ID: 6794404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: The factor VIII response to synthetic vasopressin analogues in man.
    Cash JD; Sas G
    Thromb Diath Haemorrh; 1975 Nov; 34(2):611. PubMed ID: 1198542
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure-activity relationships of vasopressin analogues on release of factor VIII in dogs.
    Vilhardt H; Barth T
    J Recept Res; 1991; 11(1-4):233-7. PubMed ID: 1715919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihaemophilic effect of vasopressin, deamino-(D-arginine8)-vasopressin and adrenaline in sheep: proposal for an in vivo assay system.
    Heiniger J; Kissling-Albrecht L; Neuenschwander S; Rösli R; Pliska V
    Br J Pharmacol; 1988 Jun; 94(2):279-81. PubMed ID: 3134968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of D.D.A.V.P. on the survival of factor VIII in severe haemophiliacs.
    McLellan DS; Knight S; McLellan HG; Wassef M; Aronstam A
    Thromb Res; 1985 Oct; 40(1):113-9. PubMed ID: 3937282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of physiological concentrations of vasopressin on haemostatic function in man.
    Grant PJ; Davies JA; Tate GM; Boothby M; Prentice CR
    Clin Sci (Lond); 1985 Oct; 69(4):471-6. PubMed ID: 3930128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial stimulation by DDAVP in von Willebrand's disease and haemophilia.
    Greer IA; McLaren M; Belch JJ; Lowe GD; Forbes CD
    Haemostasis; 1986; 16(1):15-9. PubMed ID: 3084364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of sodium pentobarbital anesthesia to alter 1-desamino-8-D-arginine vasopressin-induced elevations of plasma factor VIII/ von Willebrand factor in normal dogs.
    Johnstone IB; Crane S
    Can J Vet Res; 1988 Oct; 52(4):416-8. PubMed ID: 3143477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus.
    Kobrinsky NL; Doyle JJ; Israels ED; Winter JS; Cheang MS; Walker RD; Bishop AJ
    Lancet; 1985 Jun; 1(8441):1293-4. PubMed ID: 2860491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inability of propranolol and aspirin to inhibit the response of fibrinolytic activity and factor VIII-antigen to infusion of DDAVP.
    Brommer EJ; Derkx FH; Barrett-Bergshoeff MM; Schalekamp MA
    Thromb Haemost; 1984 Feb; 51(1):42-4. PubMed ID: 6426080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced effect of exercise and DDAVP on factor VIII-von Willebrand Factor and plasminogen activator after sequential application of both the stimuli.
    Vicente V; Alberca I; Mannucci PM
    Thromb Haemost; 1984 Feb; 51(1):129-30. PubMed ID: 6426078
    [No Abstract]   [Full Text] [Related]  

  • 18. Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility.
    Lethagen S; Harris AS; Sjörin E; Nilsson IM
    Thromb Haemost; 1987 Dec; 58(4):1033-6. PubMed ID: 3127915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of DDAVP on plasma level of factor XII.
    Nenci GG; Berrettini M; De Cunto M; Agnelli G
    Br J Haematol; 1983 Jul; 54(3):489-92. PubMed ID: 6407513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VIII procoagulant antigen recovery is a dose-related response to Factor VIII concentrate infusions.
    Taylor L; Ekert H; Dean F
    Haemostasis; 1984; 14(4):296-301. PubMed ID: 6437942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.